BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17879123)

  • 21. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay.
    Okada Y; Fujiwara Y; Yamamoto H; Sugita Y; Yasuda T; Doki Y; Tamura S; Yano M; Shiozaki H; Matsuura N; Monden M
    Cancer; 2001 Oct; 92(8):2056-64. PubMed ID: 11596020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
    Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
    Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative quantitative detection of CEA mRNA in the peritoneal lavage of gastric cancer patients with transcription reverse-transcription concerted (TRC) method. A comparative study with real-time quantitative RT-PCR.
    Ohashi N; Nakanishi H; Kodera Y; Ito S; Mochizuki Y; Koike M; Fujiwara M; Yamamura Y; Tatematsu M; Nakao A; Kato T
    Anticancer Res; 2007; 27(4C):2769-77. PubMed ID: 17695446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
    Ferrone CR; Haas B; Tang L; Coit DG; Fong Y; Brennan MF; Allen PJ
    J Gastrointest Surg; 2006 Dec; 10(10):1347-53. PubMed ID: 17175453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method].
    Ghothim M; Srovnal J; Bébarová L; Tesaříková J; Skalický P; Klos D; Prokopová A; Vahalíková M; Slavík H; Vrbková J; Neoral Č; Havlík R; Hajdúch M; Loveček M
    Rozhl Chir; 2015 Nov; 94(11):464-9; discussion 469. PubMed ID: 26766154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.
    Guller U; Zajac P; Schnider A; Bösch B; Vorburger S; Zuber M; Spagnoli GC; Oertli D; Maurer R; Metzger U; Harder F; Heberer M; Marti WR
    Ann Surg; 2002 Dec; 236(6):768-75; discussion 775-6. PubMed ID: 12454515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
    Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
    Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.
    Noura S; Yamamoto H; Ohnishi T; Masuda N; Matsumoto T; Takayama O; Fukunaga H; Miyake Y; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
    J Clin Oncol; 2002 Oct; 20(20):4232-41. PubMed ID: 12377967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
    Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma.
    Merchant NB; Conlon KC; Saigo P; Dougherty E; Brennan MF
    J Am Coll Surg; 1999 Apr; 188(4):421-6. PubMed ID: 10195727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.
    Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are "micrometastases" of the peritoneum equivalent to distant metastases?
    Kienle P; Koch M
    Dig Surg; 2002; 19(6):453-8. PubMed ID: 12499736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
    Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
    Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma?
    Schmidt J; Fraunhofer S; Fleisch M; Zirngibl H
    Hepatogastroenterology; 2004; 51(60):1827-31. PubMed ID: 15532836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer.
    Takahashi H; Akita H; Wada H; Tomokuni A; Asukai K; Takahashi Y; Yanagimoto Y; Matsunaga T; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Yamamoto T; Nakanishi M; Shirayanagi M; Yamasaki T; Ohue M; Yano M; Sakon M; Ishikawa O
    Surgery; 2018 Dec; 164(6):1168-1177. PubMed ID: 30146098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal exfoliative cytology and Ki-ras mutational analysis in patients with pancreatic adenocarcinoma.
    Rall CJ; Rivera JA; Centeno BA; Fernandez-del Castillo C; Rattner DW; Warshaw AL; Rustgi AK
    Cancer Lett; 1995 Nov; 97(2):203-11. PubMed ID: 7497464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative detection of disseminated cancer cells in the greater omentum of gastric carcinoma patients with real-time RT-PCR: a comparison with peritoneal lavage cytology.
    Kodera Y; Nakanishi H; Ito S; Yamamura Y; Kanemitsu Y; Shimizu Y; Hirai T; Yasui K; Kato T; Tatematsu M
    Gastric Cancer; 2002; 5(2):69-76. PubMed ID: 12111581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
    Tamura N; Iinuma H; Takada T
    Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymerase chain reaction for detection of carcinoembryonic antigen-expressing tumor cells on milky spots of the greater omentum in gastric cancer patients: a pilot study.
    Sakakura C; Hagiwara A; Shirasu M; Yasuoka R; Fujita Y; Nakanishi M; Aragane H; Masuda K; Shimomura K; Abe T; Yamagishi H
    Int J Cancer; 2001 Sep; 95(5):286-9. PubMed ID: 11494226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.